BUZ INVESTORS Definitive Agreement Tetra Bio-Pharma Inc. (“Tetra” orCN)announced today
CANNABIS BUZZ PRESS RELEASES

Tetra Bio-Pharma Inc. TBPMF Accelerates its Clinical Research Program in The Veterinary Market

Tetra Bio-Pharma accelerates its clinical research program in the veterinary market by entering into agreement with Dr. Louis-Philippe de Lorimier Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), today announced that it has added international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. […]

GT Biopharma OXIS  Announces Corporate Update Conference Call With Incoming CEO Dr. Kathleen Clarence-Smith
CANNABIS BUZZ PRESS RELEASES

GT Biopharma (OXISD) Announces Development Plan For Non-Opioid Neuropathic Pain Treatment “PainBrake”

GT Biopharma (OXISD) Announces Development Plan For Non-Opioid Neuropathic Pain Treatment “PainBrake” GT Biopharma Inc. announced today that it has made the required payment to license and develop PainBrake, a non-opioid pain medication, to Accu-Break Pharmaceuticals Inc. The payment allows GT Biopharma (OTCQB: OXISD) to begin the clinical development process and the filing of a […]